Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

By P. Malfertheiner, F. Mégraud, C. O'Morain, F. Bazzoli, E. El-Omar, D. Y. Graham, R. Hunt, T. Rokkas, N. Vakil, E. Kuipers. Gut, 2006

2,404 citations recorded by the source corpus.

Subfields: Epidemiology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/8377fe464985b4a1a872b8692a3620841559c737

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Vincent Wai-Sun Wong
2. G. Kaplan

In Surgery

1. D. Graham
2. E. Kuipers

Citations in the corpus

• Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption (2012, background): “Consequently, the Maastricht III Conference recommended abandoning clarithromycin in empirical treatment, or testing susceptibility for this antibiotic before using it when the prevalence of resistance is higher than 15e20%.(7) Such a prevalence rate has now been reached in most countries in Western”
• Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) (2011, neutral): “H. pylori eradication is recommended by several societies and guidelines for gastric cancer patients who undergo subtotal gas-trectomy [243 – 246].”
• Gastric cancer: epidemiology, prevention, classification, and treatment (2018, background): “The Maastricht III Guidelines recommend to treat the infection in peptic ulcer diseases, mucosa-associated lymphoid tissue lymphomas, atrophic gastritis, patients after resection of GC, first-degree relatives of GC patients, patients with unexplained iron deficiency anemia, patients with idiopathic ”
• Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report (2012, methodology): “It is well established that H pylori eradication can effectively prevent bleeding recurrence in infected patients.(3) 159 As the effect of PPI in preventing recurrent bleeding seems to be greater in H pylori-positive patients, the possibility of leaving H pylori infection untreated until the ulcer i”
• GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. (2013, result): “pylori eradication therapy results in similar rates of complete response (50e80%) in comparison with the alternatives of radiation therapy or gastrectomy [29].”
• Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. (2017, background): “It is the main cause of chronic gastritis and the principal etiological agent for gastric cancer and peptic ulcer disease.(2,6) In most regions, the main mechanism of spread is intra-familial transmission.”